Skip to main content

UBS Group AG

Position in EBS — Emergent BioSolutions Inc.

CIK 1610520 ZURICH, V8

Position in EBS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,067,170
-$196,588 QoQ
Shares Held
366,011
-6.9% QoQ
Ownership
0.714%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 194 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 74% Shared 0% None 26%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. EBS ranks #29 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EBS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,067,170 366,011
2026-03-31 $3,263,758 393,224
2025-12-31 $4,298,869 347,805
2025-09-30 $3,875,286 439,375
2025-06-30 $3,087,791 483,980
2025-03-31 $2,815,863 579,396
2024-12-31 $5,642,512 590,221
2024-09-30 $2,241,456 268,438
2024-06-30 $1,752,453 256,958
2024-03-31 $723,677 286,039
2023-12-31 $487,583 203,160
2023-09-30 $303,167 89,167
2023-06-30 $1,540,198 209,551
2023-03-31 $2,533,827 244,578
2022-12-31 $2,456,148 207,972
2022-09-30 $1,821,553 86,782
2022-06-30 $2,208,183 71,140
2022-03-31 $2,950,693 71,863
2021-12-31 $6,824,527 156,994
2021-09-30 $4,371,110 87,300
2021-06-30 $1,942,107 30,832
2021-03-31 $5,112,465 55,026
2020-12-31 $3,067,276 34,233
2020-09-30 $5,844,860 56,565
2020-06-30 $5,378,547 68,014
2020-03-31 $820,743 14,185